<html xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <meta charset="UTF-8" />
    <title>Legislation Document</title>
    <meta name="Generator" content="PowerTools for Open XML" />
    <style>span { white-space: pre-wrap; }
p.pt-Normal {
    text-align: center;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    line-height: 108%;
    margin-top: 0;
    margin-left: 0;
    margin-right: 0;
    margin-bottom: .001pt;
}
span.pt-DefaultParagraphFont {
    font-size: 10pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
span.pt-000000 {
    font-size: 10pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
table.pt-000001 {
    border-collapse: collapse;
    border: none;
    margin-left: 248.4pt;
    margin-bottom: .001pt;
}
td.pt-000002 {
    vertical-align: top;
    width: 54pt;
    border-top: none;
    border-right: none;
    padding-right: 5.4pt;
    border-bottom: none;
    border-left: none;
    padding-left: 5.4pt;
    padding-top: 0;
    padding-bottom: 0;
}
p.pt-Normal-000003 {
    font-family: 'Times New Roman', 'serif';
    font-size: 9pt;
    line-height: 108%;
    margin-top: 0;
    margin-left: 0;
    margin-right: 0;
    margin-bottom: .001pt;
}
span.pt-DefaultParagraphFont-000004 {
    font-family: 'Times New Roman', 'serif';
    font-size: 9pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
td.pt-000005 {
    vertical-align: top;
    width: 216pt;
    border-top: none;
    border-right: none;
    padding-right: 5.4pt;
    border-bottom: none;
    border-left: none;
    padding-left: 5.4pt;
    padding-top: 0;
    padding-bottom: 0;
}
p.pt-Normal-000006 {
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    line-height: 108%;
    margin-top: 0;
    margin-left: 0;
    margin-right: 0;
    margin-bottom: .001pt;
}
span.pt-DefaultParagraphFont-000007 {
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
p.pt-Normal-000008 {
    line-height: 200.0%;
    text-indent: 0.50in;
    text-align: justify;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    margin-top: 0;
    margin-left: 0;
    margin-right: 0;
    margin-bottom: .001pt;
}
span.pt-DefaultParagraphFont-000009 {
    color: #222222;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
span.pt-DefaultParagraphFont-000010 {
    color: #000000;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
p.pt-Normal-000011 {
    line-height: 200.0%;
    text-indent: 0.50in;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    margin-top: 0;
    margin-left: 0;
    margin-right: 0;
    margin-bottom: .001pt;
}
span.pt-DefaultParagraphFont-000012 {
    color: #000000;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    text-decoration: underline;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
p.pt-Normal-000013 {
    line-height: 200.0%;
    text-indent: -1.00in;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    margin-top: 0;
    margin-left: 0;
    margin-right: 0;
    margin-bottom: .001pt;
}
span.pt-DefaultParagraphFont-000014 {
    color: #000000;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
    display: inline-block;
    text-indent: 0;
    width: 1.500in;
}
span.pt-DefaultParagraphFont-000015 {
    color: #000000;
    font-size: 10pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
span.pt-000016 {
    margin: 0 0 0 0.50in;
    padding: 0 0 0 0;
}
p.pt-Normal-000017 {
    line-height: 200.0%;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    margin-top: 0;
    margin-left: 0;
    margin-right: 0;
    margin-bottom: .001pt;
}
span.pt-DefaultParagraphFont-000018 {
    color: #000000;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
    display: inline-block;
    text-indent: 0;
    width: 0.500in;
}
span.pt-DefaultParagraphFont-000019 {
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    text-decoration: underline;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
span.pt-DefaultParagraphFont-000020 {
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    font-style: normal;
    font-weight: normal;
    text-decoration: line-through;
    margin: 0;
    padding: 0;
}
span.pt-DefaultParagraphFont-000021 {
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    letter-spacing: 0.4pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
span.pt-DefaultParagraphFont-000022 {
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    letter-spacing: 0.4pt;
    text-decoration: underline;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
span.pt-DefaultParagraphFont-000023 {
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    letter-spacing: 0.75pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
span.pt-DefaultParagraphFont-000024 {
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    letter-spacing: 0.85pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
span.pt-DefaultParagraphFont-000025 {
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    letter-spacing: 0.9pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
span.pt-DefaultParagraphFont-000026 {
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    letter-spacing: 0.55pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
span.pt-DefaultParagraphFont-000027 {
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    letter-spacing: 0.5pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
span.pt-DefaultParagraphFont-000028 {
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    letter-spacing: 0.65pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
p.pt-Normal-000029 {
    line-height: 200.0%;
    text-indent: 0.38in;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    margin-top: 0;
    margin-left: 0;
    margin-right: 0;
    margin-bottom: .001pt;
}
p.pt-Normal-000030 {
    line-height: 200.0%;
    text-align: justify;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    margin-top: 0;
    margin-left: 0;
    margin-right: 0;
    margin-bottom: .001pt;
}
span.pt-DefaultParagraphFont-000031 {
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
    display: inline-block;
    text-indent: 0;
    width: 0.500in;
}
p.pt-Normal-000032 {
    line-height: 150.0%;
    text-align: center;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    margin-top: 0;
    margin-left: 0;
    margin-right: 0;
    margin-bottom: .001pt;
}
p.pt-Normal-000033 {
    text-indent: 0.50in;
    text-align: justify;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    line-height: 108%;
    margin-top: 0;
    margin-left: 0;
    margin-right: 0;
    margin-bottom: .001pt;
}
p.pt-Normal-000034 {
    margin-top: 3pt;
    line-height: 200.0%;
    text-align: right;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    margin-left: 0;
    margin-right: 0;
    margin-bottom: .001pt;
}
</style>
  </head>
  <body>
    <div>
      <p dir="ltr" class="pt-Normal">
        <span class="pt-DefaultParagraphFont">
          <img src="\Content\images\embedded\image002.jpg" />
        </span>
        <span xml:space="preserve" class="pt-000000"> </span>
      </p>
      <div align="left">
        <table dir="ltr" class="pt-000001">
          <tr>
            <td class="pt-000002">
              <p dir="ltr" class="pt-Normal-000003">
                <span xml:space="preserve" class="pt-DefaultParagraphFont-000004">SPONSOR:  </span>
              </p>
            </td>
            <td class="pt-000005">
              <p dir="ltr" class="pt-Normal-000003">
                <span class="pt-DefaultParagraphFont-000004">Sen.Â Townsend &amp; Sen.Â Poore &amp; Rep.Â Griffith &amp; Rep.Â Minor-Brown</span>
              </p>
            </td>
          </tr>
          <tr>
            <td class="pt-000005">
              <p dir="ltr" class="pt-Normal-000003">
                <span class="pt-DefaultParagraphFont-000004">Sens. Hoffner, Huxtable, Richardson, Seigfried, Sokola, Walsh; Reps. Carson, Gorman, Morrison, Romer, RossÂ Levin</span>
              </p>
            </td>
          </tr>
        </table>
      </div>
      <p dir="ltr" class="pt-Normal-000006">
        <span xml:space="preserve" class="pt-000000"> </span>
      </p>
      <p dir="ltr" class="pt-Normal">
        <span class="pt-DefaultParagraphFont-000007">DELAWARE STATE SENATE</span>
      </p>
      <p dir="ltr" class="pt-Normal">
        <span class="pt-DefaultParagraphFont-000007">153rd GENERAL ASSEMBLY</span>
      </p>
      <p dir="ltr" class="pt-Normal-000006">
        <span xml:space="preserve" class="pt-000000"> </span>
      </p>
      <p dir="ltr" class="pt-Normal">
        <span class="pt-DefaultParagraphFont-000007">SENATE BILL NO. 12</span>
      </p>
      <p dir="ltr" class="pt-Normal-000006">
        <span xml:space="preserve" class="pt-000000"> </span>
      </p>
      <p dir="ltr" class="pt-Normal-000006">
        <span class="pt-DefaultParagraphFont-000007">AN ACT TO AMEND TITLE 18 AND TITLE 29 OF THE DELAWARE CODE RELATING TO THE DELAWARE PRE AUTHORIZATION ACT OF 2025.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000006">
        <span xml:space="preserve" class="pt-000000"> </span>
      </p>
    </div>
    <div>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">WHEREAS, according to a 2023 survey of physicians conducted by the American Medical Association, physician offices spend approximately 2 business days per week dealing with insurance pre-authorization requirements and on average complete 45 pre-authorizations per physician each week; and </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">WHEREAS, in this same survey: (i) 94% of physicians reported that pre-authorization requirements have delayed necessary care for patients; (ii) 89% of physicians reported that pre-authorization requirements had a âsomewhat or  significant negative impactâ on patient clinical outcomes; (iii) 80% of physicians reported that pre-authorization requirements can lead to patients abandoning treatments; (iv) more than 60% of physicians reported that pre-authorization  requirements have led to ineffective initial treatments or additional office visits; and (v) 33% of physicians reported that  pre-authorization requirements have led to a serious adverse event (death, hospitalization, disability/permanent bodily  damage, or other life-threatening event); and  </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">WHEREAS, the General Assembly believes that reforming the laws relating to insurance pre-authorization practices is an important part of keeping Delaware residents healthy and assuring that patients can access necessary medical care in a timely manner.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">NOW, THEREFORE:</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000009">BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF DELAWARE:</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000010">Section 1. Amend Chapter 33, Title 18 of the Delaware Code by making deletions as shown by strike through and insertions as shown by underline as follows and by redesignating accordingly:</span>
      </p>
      <p dir="ltr" class="pt-Normal-000011">
        <span class="pt-DefaultParagraphFont-000010">Â§ 3371. Â Definitions.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000011">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000010">InÂ thisÂ section,Â theÂ  Â followingÂ  Â wordsÂ  Â haveÂ  Â theÂ  Â meaningsÂ indicated: </span>
      </p>
      <p dir="ltr" class="pt-Normal-000011">
        <span class="pt-DefaultParagraphFont-000012">( ) "Episode of Care" means care that meets all of the following:</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000010">Â Â </span>
      </p>
      <p dir="ltr" class="pt-Normal-000013">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000014">âââââÂ  â </span>
        <span class="pt-DefaultParagraphFont-000015">
          <span class="pt-000016">&#x00a0;</span>
        </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000010">Â </span>
        <span class="pt-DefaultParagraphFont-000012">a. Is for a specific medical problem, condition, or illness being managed by a health-care provider, including tests, procedures, and rehabilitation initially requested by the health-care provider.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000010">Â Â </span>
      </p>
      <p dir="ltr" class="pt-Normal-000017">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000018">ââââââ Â </span>
        <span class="pt-DefaultParagraphFont-000015">
          <span class="pt-000016">&#x00a0;</span>
        </span>
        <span class="pt-DefaultParagraphFont-000012">b. Is performed at the site of service.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000010">Â Â </span>
      </p>
      <p dir="ltr" class="pt-Normal-000017">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000018">ââââââ </span>
        <span class="pt-DefaultParagraphFont-000015">
          <span class="pt-000016">&#x00a0;</span>
        </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000010">Â </span>
        <span class="pt-DefaultParagraphFont-000012">c. Is not out-of-network care.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000010">Â Â </span>
      </p>
      <p dir="ltr" class="pt-Normal-000011">
        <span class="pt-DefaultParagraphFont-000019">( ) "Urgent health-care service" means a covered health-care service subject to prior authorization that is delivered on an expedited basis for the treatment of an acute condition with symptoms of sufficient severity pursuant to a determination by a licensed treating physician, operating within the physician's scope of practice and professional expertise, that the failure to provide the service is likely to result in serious, long-term health complications or a material deterioration in the covered person's or enrollee's condition and prognosis.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000011">
        <span class="pt-DefaultParagraphFont-000020">Â§</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â Â </span>
        <span class="pt-DefaultParagraphFont-000020">3372..</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000021"> </span>
        <span class="pt-DefaultParagraphFont-000022">Â§3372.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000021"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">DisclosureÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000021"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â andÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000021"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â reviewÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000021"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â ofÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000021"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â preauthorizationÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000021"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000020">requirements.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000022">requirements; </span>
        <span class="pt-DefaultParagraphFont-000019">adverse determinations.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000011">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">(c) (1) IfÂ anÂ insurer,Â health-benefitÂ plan,Â </span>
        <span class="pt-DefaultParagraphFont-000020">or</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â health-serviceÂ corporation</span>
        <span class="pt-DefaultParagraphFont-000019">, or utilization review entity</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007"> intends eitherÂ toÂ implementÂ aÂ newÂ Â preauthorizationÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000023"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â requirementÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000024"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â orÂ restriction,Â eitherÂ toÂ implementÂ aÂ newÂ preauthorizationÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000023"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">requirementÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000024"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">orÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000025"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">restriction,Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000024"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">orÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000024"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">amendÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000025"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">anÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000024"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">existingÂ Â requirementÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000025"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">orÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000024"> </span>
        <span class="pt-DefaultParagraphFont-000007">restriction,</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000024"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â theyÂ Â shallÂ provide</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000024"> </span>
        <span class="pt-DefaultParagraphFont-000007">covered personsÂ who</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000026"> </span>
        <span class="pt-DefaultParagraphFont-000007">are</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000026"> </span>
        <span class="pt-DefaultParagraphFont-000007">currentlyÂ authorizedÂ by</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000026"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">theÂ utilizationÂ reviewÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000027"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">entityÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000026"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">forÂ Â coverageÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000026"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">ofÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000026"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">the affectedÂ Â health-care service careÂ Â service andÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000026"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">allÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000028"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">contractedÂ Â health-careÂ Â providersÂ Â whoÂ Â provide Â </span>
        <span class="pt-DefaultParagraphFont-000019">the</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  affectedÂ Â health-care service or services of written noticeÂ </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000028"> </span>
        <span class="pt-DefaultParagraphFont-000007">ofÂ Â the newÂ  orÂ  amendedÂ Â requirement Â orÂ  Â amendmentÂ  noÂ  lessÂ  than 60 days before the requirement or restrictionÂ  Â is Â implemented.Â  SuchÂ  Â noticeÂ  Â may be deliveredÂ electronicallyÂ or by otherÂ means.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000029">
        <span class="pt-DefaultParagraphFont-000019">(2) Notwithstanding the provisions of paragraph (c)(1) of this section, if an insurer, health benefit plan, health-service corporation, or utilization review entity changes utilization review terms, such as clinical criteria, for a health-care service, the change in utilization review terms does not apply to covered persons with an existing authorization for the health-care service, and will apply only upon re-authorization of the health-care service. An insurer, health benefit plan, health-service corporation, or utilization review entity must provide notice to covered persons at least 6 months before any changes to utilization review terms for a health-care service, unless those changes were due to clinical guideline status changes, recalls, market withdrawals or relevant FDA published safety information.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â Â Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019"> </span>
      </p>
      <p dir="ltr" class="pt-Normal-000029">
        <span class="pt-DefaultParagraphFont-000007">(d) Insurers, health-benefit plans and health-service corporations utilizing pre-authorization shall report de-identified statistics regarding pre-authorization approvals, denials, and appeals to the Delaware Health Information Network in a format and frequency, no less than twice annually, of the Delaware Health Information Networkâs request. The Department may also request this data at any time. The statistics shall include, but may be expanded upon or further delineated by regulation, categories for all of the following</span>
        <span class="pt-DefaultParagraphFont-000019">:</span>
      </p>
      <p dir="ltr" class="pt-Normal-000011">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">(1) For denials, the aggregated reasons for denials such </span>
        <span class="pt-DefaultParagraphFont-000019">as</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000020">as, but not limited to,</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â medical necessity or </span>
      </p>
      <p dir="ltr" class="pt-Normal-000017">
        <span class="pt-DefaultParagraphFont-000007">incomplete pre-authorization submission.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000011">
        <span class="pt-DefaultParagraphFont-000007">(2) For appeals:</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000020">a.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  Â </span>
        <span class="pt-DefaultParagraphFont-000019">1.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  Practitioner </span>
        <span class="pt-DefaultParagraphFont-000020">specialty;</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">specialty.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000020">b.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  Â </span>
        <span class="pt-DefaultParagraphFont-000019">2.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  Medication, diagnostic test, or diagnostic </span>
        <span class="pt-DefaultParagraphFont-000020">procedure;</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007"> </span>
        <span class="pt-DefaultParagraphFont-000019">procedure.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000020">c.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  Â </span>
        <span class="pt-DefaultParagraphFont-000019">3.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  Indication </span>
        <span class="pt-DefaultParagraphFont-000020">offered;</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">offered.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000020">d.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  Â </span>
        <span class="pt-DefaultParagraphFont-000019">4.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  Reason for underlying </span>
        <span class="pt-DefaultParagraphFont-000020">denial;</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007"> andÂ </span>
        <span class="pt-DefaultParagraphFont-000019">denial.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000020">e.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  Â </span>
        <span class="pt-DefaultParagraphFont-000019">5.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  Number of denials overturned upon appeal.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(e) Utilization review; specific requirements related to adverse determinations â</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(1) When a clean pre-authorization request is submitted by a physician or representative of a physician, an insurer, health-benefit plan, health-service corporation, or utilization review entity must ensure that any adverse determination is made by a physician who meets all of the following requirements: </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">a. Any compensation paid to the physician is not contingent upon the outcome of the review. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">b. At least one of the following requirements is satisfied:</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">1. The physician is licensed in any United States jurisdiction with appropriate training, knowledge, or experience in the same or similar specialty that typically manages or consults on the health-care service in question. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">2. The physician is licensed in any United States jurisdiction, in consultation with an appropriately qualified third-party health-care provider licensed in the same or similar medical specialty as the requesting physician, or a health-care provider with experience related to the covered personâs associated condition. Any compensation paid to the consulting health-care provider may not be contingent upon the outcome of the review.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019"> </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(2) An insurer, health-benefit plan, health-service corporation, or utilization review entity must ensure </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">that all appeals of an adverse determination related to a clean pre-authorization request submitted by a physician or representative of a physician are reviewed and determined by a physician who meets all of the following requirements, in addition to the requirements set forth in paragraph (e)(1)</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019"> of this section:</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">a. Possesses a current, unrestricted license in good standing to practice medicine in any United States jurisdiction.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">b. Was not directly involved in making the adverse determination under appeal. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">c. Reviews and considers all clinical aspects of the health-care service under appeal, including all </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">medical records of the covered person submitted as part of the pre-authorization process.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(3) When a clean pre-authorization request is submitted by a health-care provider other than a physician, an adverse determination or review in an appeal from an adverse determination must </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">be made by a health-care provider licensed in the same or similar profession as the health-care provider submitting the request for pre-authorization, or a licensed health-care provider in consultation with an appropriately qualified third-party health-care provider licensed in the same or similar medical specialty as the requesting health-care provider. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(4) A utilization review entity must, within 15 days of the receipt of an appeal of an adverse determination, notify the covered person and health-care provider submitting the request for pre-authorization of determination on the appeal. If the utilization review entity cannot make a determination within the 15-day period because additional information, documentation, or medical records are required to complete a review of the health-care service under appeal, the utilization review entity must notify the covered person and health-care provider submitting the request for pre-authorization in writing within the 15-day period specifying the additional information, documentation, or medical records required to complete the determination on appeal and shall have 15 days from the receipt thereof to make a determination on the appeal and notify the covered person and health-care provider. The written notification</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">required by this paragraph must include all of the following:</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">a. A summary of the findings supporting the determination made in the appeal.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">b. The qualifications of any reviewer involved in making the determination in the appeal, </span>
      </p>
      <p dir="ltr" class="pt-Normal-000030">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">including any license, certification, or specialty designation of any reviewer. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">c. The relationship between the covered personâs diagnosis or disease being treated and the review criteria used as the basis for the determination in the appeal, including the specific basis for the determination made. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(5) An insurer, health-benefit plan, or health-service corporation must ensure that any utilization </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">review entity used to perform utilization review complies with all of the following: </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">a. Performs utilization review on weekends.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">b. Provides access to a medical director or other clinical decision maker Monday through Friday </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">between the hours of 7:00 AM and 7:00 PM and during reasonable business hours Saturday through Sunday.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">c. Has established procedures for the submission of appeals in writing, electronically, or by</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">telephone.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">d. Provides a minimum of 30 days from the date of an adverse determination for the submission of </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">an appeal.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â§3373. </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000020">.Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007"> Utilization review entityâs obligation with respect to pre-authorization Â </span>
        <span class="pt-DefaultParagraphFont-000020">in non-emergency</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000020">circumstances</span>
        <span class="pt-DefaultParagraphFont-000007">.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">(a) If a utilization review entity requires pre-authorization of a pharmaceutical, the utilization review</span>
      </p>
      <p dir="ltr" class="pt-Normal-000030">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">entity must complete its process or render an adverse determination and notify the covered personâs health-care provider within 2 business days of obtaining a clean pre-authorizationÂ </span>
        <span class="pt-DefaultParagraphFont-000020">or of</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â using services described in Â§ 3377 of this title. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000030">
        <span class="pt-DefaultParagraphFont-000007">(b) If a utilization review entity requires pre-authorization of a health-care service, the utilization review entity</span>
      </p>
      <p dir="ltr" class="pt-Normal-000030">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">must grant a pre-authorization or issue an adverse determination and notify the covered person's health-care provider of the determination within </span>
        <span class="pt-DefaultParagraphFont-000020">8 business</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">5Â business</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007"> days of receipt of a clean pre-authorization not submitted </span>
        <span class="pt-DefaultParagraphFont-000020">through electronic pre-authorization.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">using services described in Â§ 3377 of this title.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  For purposes of this subsection, a clean preauthorization includes the results of any face-to-face clinical evaluation or second opinion that may be required.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">(c) If a utilization review entity requires pre-authorization of a health-care service, the utilization review entity must grant a pre-authorization or issue an adverse determination and notify the covered personâs health-careÂ provider of the determination withinÂ </span>
        <span class="pt-DefaultParagraphFont-000020">5</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">3</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007"> business days of receipt of a clean pre-authorization </span>
        <span class="pt-DefaultParagraphFont-000020">through electronic pre-authorization</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007"> </span>
        <span class="pt-DefaultParagraphFont-000019">submitted using services described in Â§ 3377 of this title.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  For purposes of this subsection, a clean pre-authorization includes the results of any face-to-face clinical evaluation or second opinion that may be Â required.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(d) If a utilization review entity requires pre-authorization of an urgent health-care service, the </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">utilization review</span>
      </p>
      <p dir="ltr" class="pt-Normal-000030">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">entity must grant a pre-authorization or issue an adverse determination and notify the covered personâs health-care provider of the determination within 24 hours of receipt of a clean pre-authorization submitted using services </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">described in Â§ 3377 of this title. For purposes of this subsection, a clean pre-authorization includes the results of any face-to-face clinical evaluation or second opinion that may be required.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(e)(1) If a utilization review entity requires pre-authorization of a patient transfer, the utilization review</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">entity</span>
      </p>
      <p dir="ltr" class="pt-Normal-000030">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">must grant a pre-authorization or issue an adverse determination and notify the covered personâs health-care </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">provider of the determination within 24 hours of receipt of a clean pre-authorization submitted using services </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">described in Â§ 3377 of this title. For purposes of this subsection, a clean pre-authorization includes the results of any face-to-face clinical evaluation or second opinion that may be required.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(2) Notwithstanding the provisions in paragraph (e)(1) of this section, when an insurer, health-benefit plan, or health-service corporation has determined that a lower level of care at a health-care facility is clinically appropriate, the insurer, health benefit plan, or health-service corporation may not require pre-authorization for medically necessary interfacility transport of the covered person.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(f) If a utilization review entity requires pre-authorization of an urgent health-care service, the utilization review entity must grant a pre-authorization or issue an adverse determination and notify the covered person's health-care provider of the determination within 48 hours of receipt of a clean pre-authorization submitted not using services described in Â§ 3377 of this title. For purposes of this subsection, a clean pre-authorization includes the results of any face-to-face clinical evaluation or second opinion that may be required. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(g) If a utilization review entity requires pre-authorization of a patient transfer, the review entity must grant a pre-authorization or issue an adverse determination and notify the covered person's health-care provider of the determination within 48 hours of receipt of a clean pre-authorization not submitted using services described in Â§ 3377 of this title. For purposes of this subsection, a clean pre-authorization includes the results of any face-to-face clinical evaluation or second opinion that may be required.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â§ 3376. Â </span>
        <span class="pt-DefaultParagraphFont-000019">Effect and</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000020">Length</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019"> length </span>
        <span class="pt-DefaultParagraphFont-000007">of pre-</span>
        <span class="pt-DefaultParagraphFont-000020">authorization.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">authorization; limitation per episode of care.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">(b) A pre-authorization for a health-care service shall be valid for a period of time that is reasonable and </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">customary for the specific service, but no less thanÂ </span>
        <span class="pt-DefaultParagraphFont-000020">60 days</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â Â </span>
        <span class="pt-DefaultParagraphFont-000019">90 days</span>
        <span class="pt-DefaultParagraphFont-000007">, from the date the health-care provider receives the pre-authorization, subject to confirmation of continued coverage and eligibility and to policy changes validly Â delivered as per Â Â§ 3372 of this title.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(c) Limitation per episode of care â An insurer, health-benefit plan, or health-service corporation may not</span>
      </p>
      <p dir="ltr" class="pt-Normal-000030">
        <span class="pt-DefaultParagraphFont-000019">require more than 1 pre-authorization for an episode of care. Any new treatment or additional testing or procedures related o</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">r unrelated to the specific medical problem, condition, or illness being managed may require a separate pre-authorization.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(d) Pre-authorization of other covered services in-network - If a utilization review entity gives pre-</span>
      </p>
      <p dir="ltr" class="pt-Normal-000030">
        <span class="pt-DefaultParagraphFont-000019">authorization of a health-care service as part of a group of services for which a bundled payment is charged, pre-</span>
      </p>
      <p dir="ltr" class="pt-Normal-000030">
        <span class="pt-DefaultParagraphFont-000019">authorization of all other covered health-care services provided by in-network providers included in the group is deemed to</span>
      </p>
      <p dir="ltr" class="pt-Normal-000030">
        <span class="pt-DefaultParagraphFont-000019">be approved.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â§ 3377. Electronic standards forÂ </span>
        <span class="pt-DefaultParagraphFont-000020">pharmaceutical</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007"> pre-authorization.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(a)</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  Â No later than January 1, 2018, the insurer must accept and respond to pre-authorization requests under the pharmacy benefit through a secure electronic transmission using the NCPDP SCRIPT standard ePA transactions. Facsimile, proprietary payer portals, and electronic forms shall not be considered electronic transmission.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(b) No later than January 1, 2027, an insurer, health-benefit plan, health-service corporation, or utilization</span>
      </p>
      <p dir="ltr" class="pt-Normal-000030">
        <span class="pt-DefaultParagraphFont-000019">review entity must allow for and accept electronic pre-authorization requests and must respond to electronic pre-</span>
      </p>
      <p dir="ltr" class="pt-Normal-000030">
        <span class="pt-DefaultParagraphFont-000019">authorization requests through the same website, mobile application, digital platform, or other method as the electronic</span>
      </p>
      <p dir="ltr" class="pt-Normal-000030">
        <span class="pt-DefaultParagraphFont-000019">pre-authorization request was submitted.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(c) No later than January 1, 2027, an insurer, health-benefit plan, health-service corporation, or utilization review entity must establish a provider portal that includes all of the following features:</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(1) Electronic submission of pre-authorization requests.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(2) Access to the insurerâs, health-benefit planâs, health-service corporationâs, or utilization review entityâs applicable medical policies. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(3) Information necessary to request a peer-to-peer review.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(4) Contact information for the insurerâs, health-benefit planâs, health-service corporationâs, or utilization review entityâs relevant clinical or administrative staff.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(5) For any health-care service that requires pre-authorization that is not subject to electronic submission via the provider portal, copies of applicable forms.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(6) Instructions for the submission of pre-authorization requests if the insurerâs, health-benefit planâs, health-service corporationâs, or utilization review entityâs provider portal is unavailable for any reason. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(d) Within 12 months following establishment of a provider portal under subsection (c) of this section, the insurer, health-benefit plan, health-service corporation, or utilization review entity may require a health-care provider seeking pre-authorization to submit the request via the provider portal unless one of the following exemptions applies: </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(i) The portal is not available and operational at the time of attempted submission.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(ii) The health-care provider does not have access to the insurerâs, health-benefit planâs, health-</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">service corporationâs, or utilization review entityâs operational provider portal.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(iii) The health-care provider satisfies an allowance by the insurer, health benefit plan, health service </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">corporation, or utilization review entity for submission other than through the provider portal.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Section 2. Amend Chapter 35, Title 18 of the Delaware Code by making deletions as shown by strike through and insertions as shown by underline as follows and by redesignating accordingly: </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">Â§ 3581. Definitions. Â [For application of this section, see 82 Del. Laws, c. 44, Â§ 3].</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">For purposes of this subchapter, the following definitions apply:</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">( ) "Episode of Care" means care that meets all of the following:</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â Â </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">a. Is for a specific medical problem, condition, or illness being managed by a health-care provider, including tests, procedures, and rehabilitation initially requested by the health-care provider.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â Â </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000031">ââââ</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">b. Is performed at the site of service.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â Â </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000031">ââââ</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">c. Is not out-of-network care.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â Â </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">( ) "Urgent health-care service" means a covered health-care service subject to prior authorization that is delivered on an expedited basis for the treatment of an acute condition with symptoms of sufficient severity pursuant to a determination by a licensed treating physician, operating within the physician's scope of practice and professional expertise, that the failure to provide the service is likely to result in serious, long-term health complications or a material deterioration in the covered person's or enrollee's condition and prognosis.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â Â Â </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â§ 3582. Disclosure and review of pre-authorization Â </span>
        <span class="pt-DefaultParagraphFont-000020">requirements;</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">requirements; adverse determinations.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">(c) </span>
        <span class="pt-DefaultParagraphFont-000019">(1)</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  If an insurer, health-benefit plan, Â orÂ  health-service corporation, Â </span>
        <span class="pt-DefaultParagraphFont-000019">or utilization review entity</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  intends</span>
      </p>
      <p dir="ltr" class="pt-Normal-000030">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">either to implement a new pre-Â authorization requirement or restriction, or amend an existing requirement or restriction, they shall provide covered Â persons who are currently authorized by the utilization review entity for coverage of the affected health-care service and all Â contracted health-care providers who provide Â </span>
        <span class="pt-DefaultParagraphFont-000019">the</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  affected health care service or services of written notice of Â the new or amended requirement or amendment no less than 60 days before the requirement or restriction is Â implemented. Such notice may be delivered electronically or by other means.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(2) Notwithstanding the provisions of paragraph (c)(1) of this section, if an insurer, health benefit plan, health-service corporation, or utilization review entity changes utilization review terms, such as clinical criteria, for a health-care service, the change in utilization review terms does not apply to covered persons with an existing authorization for the health-care service, and will apply only upon re-authorization of the health-care service. An insurer, health benefit plan, health-service corporation, or utilization review entity must provide notice to covered persons at least 6 months before any changes to utilization review terms for a health-care service, unless those changes were due to clinical guideline status changes, recalls, market withdrawals or relevant FDA published safety information.Â  </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">(d) Insurers, health-benefit plans, and health-service corporations utilizing pre-authorization shall report de-</span>
      </p>
      <p dir="ltr" class="pt-Normal-000030">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">identified statistics regarding pre-authorization approvals, denials, and appeals to the Delaware Health Information Network in a format and frequency, no less than twice annually, of the Delaware Health Information Networkâs request. The Department may also request this data at any time. The statistics shall include, but may be expanded upon or further delineated by regulation, categories for all of the following: </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">(1) For denials, the aggregated reasons for denials such </span>
        <span class="pt-DefaultParagraphFont-000020">as,</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007"> </span>
        <span class="pt-DefaultParagraphFont-000020">but not limited to</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">as</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â medical necessity or incomplete pre-authorization submission. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">(2) For appeals: </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">1. Practitioner </span>
        <span class="pt-DefaultParagraphFont-000020">specialty;</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  </span>
        <span class="pt-DefaultParagraphFont-000019">specialty.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">2. Medication, diagnostic test, or diagnostic </span>
        <span class="pt-DefaultParagraphFont-000020">procedure;</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  </span>
        <span class="pt-DefaultParagraphFont-000019">procedure.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">3. Indication Â </span>
        <span class="pt-DefaultParagraphFont-000020">offered;</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  </span>
        <span class="pt-DefaultParagraphFont-000019">offered.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">4. Reason for underlyingÂ </span>
        <span class="pt-DefaultParagraphFont-000020">denial;</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007"> andÂ </span>
        <span class="pt-DefaultParagraphFont-000019">denial.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">5. Number of denials overturned upon appeal.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(e) Utilization review; Specific requirements related to adverse determinations â</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(1) When a clean pre-authorization request is submitted by a physician or representative of a physician, an insurer, health-benefit plan, health-service corporation, or utilization review entity must ensure that any adverse determination is made by a physician who meets all of the following requirements: </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">a. Any compensation paid to the physician is not contingent upon the outcome of the review. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">b. At least one of the following requirements is satisfied:</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">1. The physician is licensed in any United States jurisdiction with appropriate training, knowledge, or experience in the same or similar specialty that typically manages or consults on the health-care service in question. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">2. The physician is licensed in any United States jurisdiction, in consultation with an appropriately qualified third-party health-care provider licensed in the same or similar medical specialty as the requesting physician, or a health-care provider with experience related to the covered personâs associated condition. Any compensation paid to the consulting health-care provider may not be contingent upon the outcome of the review.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(2) An insurer, health-benefit plan, health-service corporation, or utilization review entity must ensure that all appeals of an adverse determination related to a clean pre-authorization request submitted by a physician or representative of a physician are reviewed and determined by a physician who meets all the following requirements,Â in addition to the requirements set forth in paragraph (e)(1) of this section:</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">a. Possesses a current, unrestricted license in good standing to practice medicine in any United States</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">jurisdiction.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">b. Was not directly involved in making the adverse determination under appeal.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">c. Reviews and considers all clinical aspects of the health-care service under appeal, including all </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">medical records of the covered person submitted as part of the pre-authorization process.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(3) When a clean pre-authorization request is submitted by a health-care provider other than</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019"> a physician, an adverse determination or review in an appeal from an adverse determination must be made </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">by </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">a health-care provider licensed in the same or similar profession as the health-care provider submitting the request for pre-authorization, or a licensed health-care provider in consultation with an appropriately qualified third-party health-care provider licensed in the same or similar medical specialty as the requesting health-care provider.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(4) A utilization review entity must, within 15 days of the receipt of an appeal of an adverse determination,</span>
      </p>
      <p dir="ltr" class="pt-Normal-000030">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">notify the covered person and health-care provider submitting the request for pre-authorization of the determination on the appeal. If the utilization review entity cannot make a determination within the 15-day period because </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">additional information, documentation, or medical records are required to complete a review of the health-care </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">service under appeal, the utilization review entity must notify the covered person and health-care provider </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">submitting the request for pre-authorization in writing within the 15-day period specifying the additional information, </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">documents, or medical records required to complete the determination on appeal and shall have 15 days from the </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">receipt thereof to make a determination on the appeal and notify the covered person and health-care provider. The </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">written notification required by this paragraph must include all of the following:</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">a. A summary of the findings supporting the determination made in the appeal.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">b. The qualifications of any reviewer involved in making the determination in the appeal, including any license, certification, or specialty designation of any reviewer.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">c. The relationship between the covered personâs diagnosis or disease being treated and the review criteria used as the basis for the determination in the appeal, including the specific basis for the determination made.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(5) An insurer, health-benefit plan, or health-service corporation must ensure then that any utilization </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">review entity used to perform utilization review complies with all of the following:</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">a. Performs utilization review on weekends.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">b. Provides access to a medical director or other clinical decision-maker Monday through Frida</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">y between the hours of 7:00 AM to 7:00 PM and during reasonable business hours Saturday through Sunday.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">c. Has established procedures for the submission of appeals in writing, electronically, or by telephone.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  Â </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">d. Provides a minimum of 30 days from the date of an adverse determination for the submission of </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">an appeal.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019"> </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â§ 3583. Utilization review entityâs obligations with respect to pre-authorizationsÂ </span>
        <span class="pt-DefaultParagraphFont-000020">in non-emergency Â circumstances</span>
        <span class="pt-DefaultParagraphFont-000007">.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">(a) If a utilization review entity requires pre-authorization of a pharmaceutical, the utilization review Â entity must complete its process or render an adverse determination and notify the covered personâs health-care provider Â within 2 business days of obtaining a clean pre-authorization Â or ofÂ  using services described in Â </span>
        <span class="pt-DefaultParagraphFont-000020">Â§ 3377</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007"> Â§ Â </span>
        <span class="pt-DefaultParagraphFont-000019">3587</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007"> Â of Â this title.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">(b) If a utilization review entity requires pre-authorization of a health-care service, the utilization review entity must grant a pre-authorization or issue an adverse determination and notify the covered personâs health-care provider of the determination within </span>
        <span class="pt-DefaultParagraphFont-000020">8 business</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">5 business</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â days of receipt of a clean pre-authorizationÂ </span>
        <span class="pt-DefaultParagraphFont-000020">through electronic pre-authorization</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â not submitted </span>
        <span class="pt-DefaultParagraphFont-000019">using services described in Â§ 3587 of this title.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  For purposes of this subsection, a clean pre-authorization includes the results of any face-to-face clinical evaluation or second opinion that may be required.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">(c) If A utilization review entity requires pre-authorization of a health-care service, the utilization review entity must grant a pre-authorization or issue an adverse determination and notify the covered personâs health-care provider of the determination within </span>
        <span class="pt-DefaultParagraphFont-000020">5</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">3</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â business days of receipt of a clean pre-authorizationÂ </span>
        <span class="pt-DefaultParagraphFont-000020">through electronic pre-authorization.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">submitted using services described in Â§ 3587 of this title.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  For purposes of this subsection, a clean pre-authorization includes the results of any face-to-face clinical evaluation or second opinion that may be required.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(d) If a utilization review entity requires pre-authorization of an urgent health-care service, the utilization</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">review entity must grant a pre-authorization or issue an adverse determination and notify the covered personâs health-care</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">provider of the determination within 24 hours of receipt of a clean pre-authorization submitted using services described in </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">Â§ 3587 of this title. For purposes of this subsection, a clean pre-authorization includes the results of any face-to-face clinical evaluation or second opinion that may be required. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(e)(1) If a utilization review entity requires pre-authorization of a patient transfer, the utilization review entity must grant a pre-authorization or issue an adverse determination and notify the covered personâs health-care provider of the determination within 24 hours of receipt of a clean pre-authorization submitted using services described in </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">Â§ 3587 of</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019"> </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">this title. For purposes of this subsection, a clean pre-authorization includes the results of any face-to-face clinical evaluation or second opinion that may be required.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(2) Notwithstanding the provisions in paragraph (e)(1) of this section, when an insurer, health-benefit</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">plan or health-service corporation has determined that a lower level of care at a health-care facility is clinically appropriate, </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">the insurer, health benefit plan, or health-service corporation may not require pre-authorization for medically necessary </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">interfacility transport of the covered person.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(f) If a utilization review entity requires pre-authorization of an urgent health-care service, the utilization review entity must grant a pre-authorization or issue an adverse determination and notify the covered person's health-care provider of the determination within 48 hours of receipt of a clean pre-authorization submitted not using services described in Â§ 3587 of this title. For purposes of this subsection, a clean pre-authorization includes the results of any face-to-face clinical evaluation or second opinion that may be required. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(g) If a utilization review entity requires pre-authorization of a patient transfer, the review entity must grant a pre-authorization or issue an adverse determination and notify the covered person's health-care provider of the determination within 48 hours of receipt of a clean pre-authorization not submitted using services described in Â§ 3387 of this title. For purposes of this subsection, a clean pre-authorization includes the results of any face-to-face clinical evaluation or second opinion that may be required.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â§ 3586. Â </span>
        <span class="pt-DefaultParagraphFont-000020">Length</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007"> </span>
        <span class="pt-DefaultParagraphFont-000019">Effect and length</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â of pre-Â </span>
        <span class="pt-DefaultParagraphFont-000020">authorization.</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  </span>
        <span class="pt-DefaultParagraphFont-000019">authorization; limitation per episode of care.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">(b) A pre-authorization for a health-care service shall be valid for a period of time that is reasonable and customary for the specific service, but no less than Â </span>
        <span class="pt-DefaultParagraphFont-000020">60 days</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  9</span>
        <span class="pt-DefaultParagraphFont-000019">0 days,</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â  from the date the health-care provider receives Â the pre-authorization, subject to confirmation of continued coverage and eligibility and to policy changes validly deliveredÂ  Â as per Â§ 3582 of this title.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(c) Limitation per episode of care â An insurer, health-benefit plan, or health-service corporation may not require more than 1 pre-authorization for an episode of care. Any new treatment or additional testing or procedures related or unrelated to the specific medical problem, condition, or illness being managed may require a separate pre-authorization. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(d) Pre-authorization of other covered services in-network - If a utilization review entity gives pre-authorization of a health-care service as part of a group of services for which a bundled payment is charged, pre-authorization of all other covered health-care services provided by in-network providers included in the group is deemed to be approved.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â§ 3587. Electronic standards for </span>
        <span class="pt-DefaultParagraphFont-000020">pharmaceutical</span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â pre-authorization.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">(a) No later than January 1, 2018, the insurer must accept and respond to pre-authorization requests under the pharmacy benefit through a secure electronic transmission using the NCPDP SCRIPT standard ePA transactions. Facsimile, proprietary payer portals, and electronic forms shall not be considered electronic transmission.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(b) No later than January 1, 2027, an insurer, health-benefit plan, health-service corporation, or utilization review entity must allow for and accept electronic pre-authorization requests and must respond to electronic pre-authorization requests through the same website, mobile application, digital platform, or other method as the electronic pre-authorization request was submitted. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(c) No later than January 1, 2027, an insurer, health-benefit plan, health-service corporation, or utilization review entity must establish a provider portal that includes all of the following features: </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(1) Electronic submission of pre-authorization requests. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(2) Access to the insurerâs, health-benefit planâs, health-service corporationâs, or utilization review entityâs applicable medical policies. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(3) Information necessary to request a peer-to-peer review.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(4) Contact information for the insurerâs, health-benefit planâs, health-service corporationâs, or utilization review entityâs relevant clinical or administrative staff. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(5) For any health-care service that requires pre-authorization that is not subject to electronic submission via the provider portal, copies of applicable forms. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(6) Instructions for the submission of pre-authorization requests if the insurerâs, health-benefit planâs, health-service corporationâs, or utilization review entityâs provider portal is unavailable for any reason. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(d) Within 12 months following establishment of a provider portal under subsection (c) of this section, the insurer, health-benefit plan, health-service corporation, or utilization review entity may require a health-care provider seeking pre-authorization to submit the request via the provider portal unless one of the following exemptions applies:</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(i) The portal is not available and operational at the time of attempted submission.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">(ii) The health-care provider does not have access to the insurerâs, health-benefit planâs, health service corporationâs, or utilization review entityâs operational provider portal. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000019">(iii) The health-care provider satisfies an allowance by the insurer, health benefit plan, health service corporation, or utilization review entity for submission other than through the provider portal.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">Section 3. Amend Â§ 5210, Title 29 of the Delaware Code by making deletions as shown by strikethrough and insertions as shown by underline as follows:</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â§ 5210. Authority and duties of the State Employee Benefits Committee.Â  </span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">The State Employee Benefits Committee established underÂ Â§ 9602 of this title has the following powers, duties, and functions under this chapter:</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000019">( ) Ensure that carriers administering plans for group health insurance under this chapter comply with all requirements and provisions concerning </span>
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Â </span>
        <span class="pt-DefaultParagraphFont-000019">pre-authorization set forth in Chapter 33, Subchapter II, and Chapter 35, Subchapter V of Title 18.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">Section 4. Effective Date. This Act shall apply to all health insurance policies, contracts, or certificates issued, renewed, modified, altered, amended or reissued in this state after December 31, 2026.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Section 5. The Department of Health and Social Services must, to the extent feasible, assure that contracts awarded to carriers providing health insurance under Â§ 505(3) of Title 31 after the effective date of this Act include the </span>
      </p>
      <p dir="ltr" class="pt-Normal-000030">
        <span class="pt-DefaultParagraphFont-000007">requirements and provisions concerning pre-authorization set forth in Chapter 33, Subchapter II and Chapter 35, Subchapter V of Title 18.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">Section 6. This Act shall be known as and may be referred to as the âDelaware Pre-Authorization Reform Act of 2025â.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000030">
        <span xml:space="preserve" class="pt-000000"> </span>
      </p>
    </div>
    <div>
      <p dir="ltr" class="pt-Normal-000032">
        <span class="pt-DefaultParagraphFont-000019">SYNOPSIS</span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont-000007">This Legislation is the Delaware Pre-Authorization Reform Act of 2025.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont"></span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Section 1 of the Act applies to health Insurance Contracts regulated under Chapter 33 of Title 18. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont"></span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Section 1 provides that changes in utilization review terms for a health-care service, such as the clinical criteria used to conduct utilization reviews for a health-care service, will apply only upon re-authorization of the health-care service. Covered persons must be notified at least 6 months before any changes to utilization review terms, except in certain circumstances such as changes in clinical guideline status </span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont"></span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont-000007">In addition, Section 1 sets qualifications for who may make determinations with regard to requests for pre- authorization of health-care services and appeals of adverse determinations; a timeline and required contents for the notification of an outcome of appeal of an adverse determination or a notification that additional information is necessary to make the determination of appeal; and requirements for any utilization review entity used to perform utilization review by an insurer, health-benefit plan, or health-service corporation.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont"></span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont-000007">Section 1 also shortens the timelines for the determination of pre-authorization requests and notification to the health-care provider of the determination. For requests for pre-authorization of non-urgent health-care services not submitted electronically, the utilization review entity must notify the health-care provider within 5 business days of receipt of the request; for requests submitted electronically, notification must be given within 3 business days of receipt. For requests for pre-authorization for urgent health-care services submitted electronically, notification must be given within 24 hours of receipt.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont"></span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont-000007">By January 1, 2027, insurers, health-benefit plans, health-service corporations, and utilization review entities must accept and respond to electronic pre-authorization requests through the same platform as the electronic request was submitted.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont"></span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont-000007">In addition, Section 1 extends the time period that a pre-authorization is valid for from 60 days to 90 days. Finally, Section 1 provides that no more than 1 pre-authorization may be required for a single episode of care, and that if pre-authorization is granted as to a health-care service that is part of a group of services for which a bundled payment is charged, pre-authorization for the other health-care services included in the group is deemed to be approved as well.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont"></span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont-000007">Section 2 of the Act applies to Group and Blanket Health Insurance under Chapter 35 of Title 18 and makes the same changes to pre-authorization standards and procedures that Section 1 of the Act makes to Health Insurance Contracts regulated under Chapter 33 of Title 18.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont"></span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont-000007">Section 3 of the Act provides that the State Employee Benefits Committee established under Â§ 9602 of the Title 29 of the Delaware Code must ensure that carriers administering plans for group health insurance comply with the requirements and provisions for pre-authorization set forth in Chapter 33, Subchapter II and Chapter 35, Subchapter V of Title 18.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont"></span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span xml:space="preserve" class="pt-DefaultParagraphFont-000007">Section 4 of the Act provides that the Act will apply to health insurance policies, contracts, or certificates issued, modified, or renewed after December 31, 2026. </span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont"></span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont-000007">Section 5 of the Act provides that the Department of Health and Social Services must, to the extent feasible, assure that contracts awarded to carriers providing health insurance relating to Medicaid assistance comply with the requirements and provisions for pre-authorization set forth in Chapter 33, Subchapter II and Chapter 35, Subchapter V of Title 18.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont"></span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont-000007">Section 6 provides that this Act is known as the "Delaware Pre-Authorization Reform Act of 2025."</span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont"></span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont"></span>
      </p>
      <p dir="ltr" class="pt-Normal-000033">
        <span class="pt-DefaultParagraphFont"></span>
      </p>
      <p dir="ltr" class="pt-Normal-000034">
        <span class="pt-DefaultParagraphFont-000007">Author: Senator Townsend</span>
      </p>
    </div>
  </body>
</html>